Wang Ye, Wu Meng, Zhao Lin, Yan Xiaojian, Zhao Lei
Department of Anesthesiology, Peking University Shougang Hospital, Beijing, China.
Department of Anesthesiology, Xuanwu Hospital Affiliated with Capital Medical University, Beijing, China.
Front Surg. 2024 Apr 24;11:1382759. doi: 10.3389/fsurg.2024.1382759. eCollection 2024.
BACKGROUND: We aimed to compare the anesthesia induction effects of oxycodone and sufentanil on postoperative pain in patients undergoing laparoscopic gallbladder-preserving cholecystolithotomy, as well as changes in serum levels of inflammatory factors (TNF-α, IL-6, and IL-10) in the perioperative period. METHODS: Sixty patients who underwent laparoscopic gallbladder-preserving cholecystolithotomy were evenly divided into oxycodone (O) and sufentanil (S) groups. In groups O and S, oxycodone (0.3 mg/kg) and sufentanil (0.3 ug/kg) were administered, respectively, followed by propofol (2 mg/kg) and rocuronium (0.6 mg/kg). In both groups, the intraoperative electroencephalography double-frequency index was used to guide the use of sedative and analgesic drugs, assessing the follow-up analgesic effect (VAS), degree of sedation (Ramsey), and postoperative complications at seven different time points (0, 0.5, 2, 4, 6, 8, and 24 h postoperatively). RESULTS: Compared with the S group, patients in the O group exhibited lower VAS scores within 24 h postoperatively ( < 0.001), but there was no statistical difference between wound and shoulder pain scores (> 0.05). Regarding postoperative awakening and extubation duration, O group patients experienced shorter times and better remedial analgesia ( < 0.05). In terms of the degree of sedation, the Ramsay score decreased at 0 h postoperatively compared with the S group ( < 0.001). CONCLUSION: Compared with sufentanil, oxycodone anesthesia induced better postoperative analgesia and less inflammatory responses in patients undergoing laparoscopic gallbladder-preserving cholecystolithotomy. CLINICAL TRIAL REGISTRATION: This study has been approved by the Ethics Committee of Peking University Shougang Hospital, with ethical approval (No. IRBK-2020-009), and has completed registration in the Chinese Clinical Trials Register (http://www.chictr.org.cn/) (ChiCTR2000031230).
背景:我们旨在比较羟考酮和舒芬太尼对行腹腔镜保胆取石术患者术后疼痛的麻醉诱导效果,以及围手术期血清炎症因子(TNF-α、IL-6和IL-10)水平的变化。 方法:60例行腹腔镜保胆取石术的患者被均匀分为羟考酮(O)组和舒芬太尼(S)组。在O组和S组中,分别给予羟考酮(0.3 mg/kg)和舒芬太尼(0.3 μg/kg),随后给予丙泊酚(2 mg/kg)和罗库溴铵(0.6 mg/kg)。两组均采用术中脑电图双频指数指导镇静和镇痛药物的使用,评估七个不同时间点(术后0、0.5、2、4、6、8和24 小时)的随访镇痛效果(VAS)、镇静程度(Ramsey)和术后并发症。 结果:与S组相比,O组患者术后24小时内VAS评分更低(<0.001),但伤口和肩部疼痛评分之间无统计学差异(>0.05)。关于术后苏醒和拔管时间,O组患者时间更短且补救性镇痛更好(<0.05)。在镇静程度方面,与S组相比,术后0小时Ramsay评分降低(<0.001)。 结论:与舒芬太尼相比,羟考酮麻醉对行腹腔镜保胆取石术的患者术后镇痛效果更好,炎症反应更少。 临床试验注册:本研究已获得北京大学首钢医院伦理委员会批准,伦理批准号(No. IRBK-2020-009),并已在中国临床试验注册中心(http://www.chictr.org.cn/)完成注册(ChiCTR2000031230)。
Ann Surg. 2021-10-1
BMC Anesthesiol. 2021-7-21
J Opioid Manag. 2018
Genet Mol Res. 2015-5-11
J Korean Surg Soc. 2013-10